BMAL1 and nonpapillary renal cell carcinoma: Despite the divergent impacts on gene expression of depleting ARNT or BMAL1 in ccRCC patient-derived cell lines, losing either of these HIF2α partners dramatically reduces the ability of several ccRCC cell lines to form colonies in vitro and xenograft tumors in vivo.